Is restless legs syndrome underrecognized? Current management

Joint Bone Spine

Volumn 73, Issue 4, 2006, Pages 369-373

  Vergne Salle, Pascale ^a   Coyral, Damien ^a   Dufauret, Karine ^a   Bonnet, Christine ^a   Bertin, Philippe ^a   Trèves, Richard ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Dopamine agonists; Periodic leg movements; Restless legs syndrome; Rheumatoid arthritis; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CARBAMAZEPINE; CLONAZEPAM; CODEINE; DEXTROPROPOXYPHENE; DIHYDROCODEINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; GLUCOCORTICOID; LEVODOPA; LITHIUM; METHADONE; METOCLOPRAMIDE; OPIATE; OXYCODONE; PERGOLIDE; RACLOPRIDE C 11; ROPINIROLE; TILIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ABDOMINAL PAIN; ADDICTION; ASTHENIA; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DIABETES MELLITUS; DISEASE SEVERITY; DROWSINESS; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSESTHESIA; DYSKINESIA; HUMAN; HYPOTENSION; IRON DEFICIENCY; KIDNEY FAILURE; LEG MOVEMENT; NAUSEA; NEUROLOGIC DISEASE; POLYSOMNOGRAPHY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; RHEUMATOID ARTHRITIS; RHINITIS; SHORT SURVEY; SLEEP; SLEEP APNEA SYNDROME; VERTIGO; VOMITING;

DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; HUMANS; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 33745832746     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2005.03.012     Document Type: Short Survey

References (38)

1. Monaca C., and Derambure P. Prise en charge des impatiences et des mouvements périodiques au cours du sommeil. Rev. Neurol. 160 (2004) 739-744
2. Hening W. The clinical neurophysiology of restless legs syndrome and periodic limb movements/ Part I: diagnosis, assessment, and characterization. Clin. Neurophysiol. 115 (2004) 1965-1974
3. The International Restless Legs Syndrome Study Group. Walters AS. Toward a better definition of the restless legs syndrome. Mov. Disord. 10 (1995) 634-642
4. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 4 (2003) 101-119
5. Lavigne G.J., and Montplaisir J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17 (1994) 739-743
6. Phillips B., Young T., Finn L., Asher K., Hening W.A., and Purvis C. Epidemiology of restless legs symptoms in adults. Arch. Intern. Med. 160 (2000) 2137-2141
7. Berger K., Luedemann J., Trenkwalder C., John U., and Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch. Intern. Med. 164 (2004) 196-202
8. Trenkwalder C., Walters A.S., and Hening W. Periodic limb movements and restless legs syndrome. Neurol. Clin. 14 (1996) 629-650
9. Zucconi M., and Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 5 (2004) 293-299
10. Collado-Seidel V., Winkelmann J., and Trenkwalder C. Aetiology and treatment of restless legs syndrome. CNS Drugs 12 (1999) 9-20
11. Reynolds G., Blake D.R., Pall H.S., and Williams A. Restless legs syndrome and rheumatoid arthritis. BMJ 292 (1986) 659-660
12. Salih A.M., Gray R.E.S., Mills K.R., and Webley M. A clinical, serological, and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br. J. Rheumatol. 33 (1994) 60-63
13. Gibb W.R.G., and Lees A.J. The restless legs syndrome. Postgrad. Med. J. 37 (1986) 393-406
14. Yunus M.B., and Aldag J.C. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. Brit. Med. J. 312 (1996) 1339
15. Montplaisir J., Lorrain D., and Godbout R. restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur. Neurol. 31 (1991) 41-43
16. Bucher S.F., Seelos K.C., Oertel W.H., Reiser M., and Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann. Neurol. 41 (1997) 639-645
17. Trenkwalder C., Walters A.S., Hening W.A., Chokroverty S., Antonini A., Dhawan V., et al. Positron emission tomographic studies in the restless legs syndrome. Mov. Disord. 1 (1999) 141-145
18. Trenkwalder C., and Paulus W. Why do restless legs occur at rest? Pathophysiology of neuronal structures in RLS. Neurophysiology of RLS. Clin. Neurophysiol. 115 (2004) 1975-1988 [part 2]
19. Hening W., Walters A.S., Allen R.P., Montplaisir J., Myers A., and Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST primary care study. Sleep Med. 5 (2004) 237-246
20. Brodeur C., Montplaisir J., Godbout R., and Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with l-dopa: a double-blind, controlled study. Neurology 38 (1988) 1845-1848
21. Kaplan P.W., Allen R.P., Buchholz D.W., and Walters J.K. A double-blind placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 16 (1993) 717-723
22. Trenkwalder C., Stiasny K., Pollmacher T., Wetter T., Schwarz J., Kohnen R., et al. l-DOPA therapy of uraemic and idiopathic restless legs syndrome: a double-blind crossover trial. Sleep 18 (1995) 681-688
23. Collado-Seidel V., Kazenwadel J., Wetter T.C., Kohnen R., Winkelmann J., Selzer R., et al. A controlled study of additional sr-l-dopa in l-dopa responsive restless legs syndrome with late night symptoms. Neurology 52 (1999) 285-290
24. Comella C.L. Restless legs syndrome. Treatment with dopaminergic agents. Neurology 58 (2002) S87-S92
25. Trenkwalder C., Garcia-Borreguero D., Montagna P., Lainey E., De Weerd A.W., Tidswell P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomized, placebo controlled study in 10 European countries. J. Neurol. Neurosurg. Psychiatry 75 (2004) 92-97
26. Walters A.S., Ondo W.G., and Dreykluft T. On behalf of the TREAT RLS 2 study group. Ropinirole is effective in the treatment of restless legs syndrome: a 12 week, double blind, randomized, parallel-group, placebo-controlled study. Mov. Disord. 19 (2004) 1414-1423
27. Adler C.H., Hauser R.A., Sethi K., Caviness J.N., Marlor L., Anderson W.M., et al. Ropinirole for restless legs syndrome. A placebo-controlled crossover trial. Neurology 62 (2004) 1405-1407
28. Allen R.P., Becker P.M., and Bogan R. Ropinirole decreases periodic leg movement and improves sleep parameters in patients with restless legs syndrome. Sleep 27 (2004) 907-914
29. Schapira A.H.V. Restless legs syndrome. An update on treatment options. Drugs 64 (2004) 149-158
30. Walters A.S. Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med. 3 (2002) 301-304
31. Walters A.S., Wagner M.L., Hening W.A., Grasing K., Mills R., Chokroverty S., et al. Successful treatment of idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16 (1993) 327-332
32. Walters A.S., Winkelmann J., Trenkwalder C., Fry J.M., Kataria V., Wagner M., et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov. Disord. 16 (2001) 1105-1109
33. Perrot S., Bannwarth B., Bertin P., Javier R.M., Glowinski J., Le Bars M., et al. Utilisation de la morphine dans les douleurs rhumatologiques non cancéreuses: les recommandations de Limoges. Rev. Rhum. 66 (1999) 651-657 [Ed Fr]
34. Agence française de sécurité sanitaire des produits de santé (AFSSAPS). Mise au point sur le bon usage des opioïdes forts dans le traitement des douleurs chroniques non cancéreuses. See the AFSSAPS: internet site: http://agmed.sante.gouv.fr/htm/10/opioide/mapopio.pdf.
35. Lundvall O., Abom P.E., and Holm R. Carbamazepine in restless legs: a controlled pilot study. Eur. J. Clin. Pharmacol. 25 (1983) 323-324
36. Telstad W., Sorensen O., and Larsen S. Treatment of the restless legs syndrome with carbamazepine: a double blind study. BMJ 288 (1984) 444-446
37. Garcia-Borreguero D., Larrosa O., de la Liave Y., Verger K., Masramon X., and Hernandez G. Treatment of restless legs syndrome with gabapentin. Neurology 59 (2002) 1573-1579
38. Happe S., Sauter C., Klösch G., Saletu B., and Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 48 (2003) 82-86